Ribonuclease P: A Key Enzyme in DNA Repair and Gene Expression

Target Name: RPP14

NCBI ID: G11102

RPP14

Ribonuclease P: A Key Enzyme in DNA Repair and Gene Expression

Ribonuclease P (RPN) is a key enzyme in the DNA repair pathway, which is responsible for repairing damage to DNA caused by various types of stressors, such as radiation, chemicals, or mutations. Ribonuclease P is a subunit of the complex DNA repair enzyme Mrp (MutL-related protein), which also includes the protein N-terminal BP1 (N-terminal B repair factor 1).

The RPN subunit is a single molecule that contains 116 amino acid residues and is located within the N-end of the MRP subunit. It has a unique structure that includes a catalytic active site, a binding site for the DNA target, and a C- terminus that is involved in interactions with various cellular signaling pathways.

RPN has been shown to play a critical role in the regulation of DNA repair pathways in various organisms, including bacteria, yeast, and mammalian cells. It is a potent inhibitor of DNA damage repair processes, which has potential as a drug target for diseases caused by DNA damage.

One of the unique features of RPN is its ability to recognize specific DNA sequences that are compatible with its catalytic active site. This allows RPN to cleave DNA at specific sites, which is critical for the repair of damaged DNA.

In addition to its role in DNA repair, RPN has also been shown to play a critical role in the regulation of gene expression. It has been shown to interact with various transcription factors, including the T-cell factor Myb, to regulate the expression of target genes.

RPN has also been shown to play a critical role in the regulation of cellular signaling pathways. It has been shown to interact with various signaling pathways, including the TOR signaling pathway, to regulate cellular processes such as cell growth, metabolism, and apoptosis.

Due to its unique structure and its critical role in various cellular processes, RPN has potential as a drug target for diseases caused by DNA damage. Several studies have shown that inhibiting RPN has potential to treat various diseases, including cancer, neurodegenerative diseases, and inherited diseases.

In addition to its potential as a drug target, RPN also has potential as a biomarker for various diseases. Its ability to recognize specific DNA sequences and its role in the regulation of cellular signaling pathways make it an attractive candidate for diagnostic applications.

In conclusion, RPN is a unique and critical enzyme in the DNA repair pathway that has potential as a drug target and biomarker. Further research is needed to fully understand its role in various cellular processes and its potential as a therapeutic agent.

Protein Name: Ribonuclease P/MRP Subunit P14

Functions: Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends

The "RPP14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPP14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets